Bovine Tuberculosis Diagnosis Market By Test (Serological Tests, Molecular Diagnostic Tests, Traditional Tests), and By Region; Global Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Bovine Tuberculosis Diagnosis Market was valued at USD 585.4 million in 2023 and will surpass USD 871.3 million by 2030; growing at a CAGR of 5.8% during 2024 - 2030.

The bovine tuberculosis (bTB) diagnosis market plays a critical role in global efforts to control the spread of tuberculosis among cattle populations, which can have severe economic and public health implications. Bovine tuberculosis is a chronic bacterial disease primarily caused by Mycobacterium bovis, and its diagnosis is essential for ensuring the health of livestock and preventing transmission to humans. The market for bTB diagnostics has seen significant advancements in recent years, with the development of new and more effective diagnostic tools that help farmers, veterinarians, and authorities detect the disease early, mitigate its spread, and ensure compliance with regulatory standards. The rising demand for accurate and rapid detection methods is being driven by the increased awareness of zoonotic diseases, the global demand for safe animal products, and government policies focused on animal health.

As the industry faces increasing concerns about zoonotic diseases and the impact of bTB on the agricultural economy, innovative diagnostic tests are being developed to meet the need for quick, reliable, and cost-effective solutions. The adoption of molecular and serological tests, in addition to traditional methods, is growing, as these technologies offer enhanced sensitivity and faster results. The market is seeing a shift towards more advanced molecular diagnostic tests, which provide more accurate and faster results compared to conventional methods, making them increasingly popular among farmers and veterinary professionals.

Serological Tests Are Fastest Growing Due to Their Accessibility and Affordability

Serological tests have emerged as one of the fastest-growing segments in the bovine tuberculosis diagnosis market, largely due to their accessibility, affordability, and ease of use. These tests detect antibodies or antigens in an animal’s blood, offering a relatively quick method for diagnosing bovine tuberculosis. The primary advantage of serological tests lies in their simplicity and cost-effectiveness compared to more complex diagnostic methods. In many regions, especially in developing countries, the affordability and ease of administration make serological tests the preferred choice for initial screening of cattle for bTB.

Additionally, serological tests have improved in sensitivity and specificity over the years, making them a valuable tool for routine testing in both small- and large-scale farming operations. While they may not always be as definitive as molecular diagnostic tests, serological tests are an excellent first step in the diagnostic process, allowing for quicker identification of potentially infected animals. The increasing adoption of serological tests is also facilitated by government regulations and programs aimed at controlling bTB outbreaks, which require affordable and efficient diagnostic solutions.

Molecular Diagnostic Tests Lead in Accuracy and Speed for Bovine Tuberculosis Detection

Molecular diagnostic tests, particularly PCR (Polymerase Chain Reaction) assays, have become the leading method in the bovine tuberculosis diagnosis market due to their high accuracy, sensitivity, and speed. These tests can detect the genetic material of Mycobacterium bovis in samples, enabling quicker and more precise diagnosis of the disease. Molecular diagnostics, by providing results within hours, are particularly useful in cases where time is critical for managing outbreaks and preventing further spread. They also offer the advantage of higher specificity compared to traditional methods, reducing the likelihood of false positives or negatives.

In addition to their diagnostic precision, molecular tests are highly valued for their ability to differentiate between bTB and other similar diseases, thus ensuring the correct diagnosis. These factors contribute to the growing adoption of molecular diagnostic tests, especially in countries with robust veterinary infrastructure and where the control of bovine diseases is a high priority. As technology advances, molecular tests are expected to become more accessible and affordable, further driving their market growth.

North America Leads the Bovine Tuberculosis Diagnosis Market

North America holds the largest market share in the bovine tuberculosis diagnosis market, primarily due to the region’s advanced healthcare systems, well-established animal health regulations, and strong focus on animal disease control. The U.S. and Canada have implemented rigorous testing protocols for the detection of bovine tuberculosis, aiming to protect both livestock populations and public health. Government agencies, such as the U.S. Department of Agriculture (USDA) and the Canadian Food Inspection Agency (CFIA), play an instrumental role in setting standards and promoting the adoption of effective diagnostic methods for bTB.

In the U.S., for instance, the eradication of bovine tuberculosis has been an ongoing priority, with regular testing being a requirement for cattle moving across state lines and being processed for consumption. As a result, there is a high demand for reliable and fast diagnostic tools, with molecular diagnostic tests and serological tests being widely used in the region. The commitment of North American countries to maintaining strict animal health standards and reducing the risk of zoonotic diseases ensures that the region remains the dominant player in the global bovine tuberculosis diagnosis market.

Competitive Landscape: Key Players and Market Trends

The bovine tuberculosis diagnosis market is competitive, with several key players leading the development and distribution of advanced diagnostic tools. Major companies in the market include Thermo Fisher Scientific, Biomerieux, Qiagen, and IDEXX Laboratories, among others. These companies offer a wide range of products, including both traditional tests like the tuberculin skin test and more advanced molecular and serological tests. As the demand for more accurate and faster testing methods continues to rise, these companies are investing in research and development to introduce innovative solutions that meet the needs of veterinary professionals and agricultural businesses.

The competitive landscape is also influenced by partnerships and collaborations between diagnostic companies, research institutions, and government agencies. These partnerships aim to enhance the development of novel testing methods, ensuring that they meet regulatory standards and can be effectively implemented in diverse geographical regions. As the market continues to grow, companies are focusing on enhancing the affordability, ease of use, and scalability of their diagnostic solutions to cater to the increasing demand in both developed and emerging markets. The ability to offer cost-effective, reliable, and timely testing solutions will be a key factor in maintaining a competitive edge in the bovine tuberculosis diagnosis market.

Recent Developments:

• In February 2024, Thermo Fisher Scientific launched an advanced PCR-based diagnostic test for Bovine Tuberculosis, offering enhanced sensitivity and faster results.
• In January 2024, IDEXX Laboratories received approval for its new ELISA-based Bovine TB test, aimed at improving accuracy in early-stage detection of Mycobacterium bovis in cattle.
• In December 2023, HerdX entered into a partnership with Oxford Immunotec to enhance the development of new diagnostic tests for Bovine Tuberculosis using interferon-gamma assays.
• In November 2023, BioNote Inc. unveiled a new rapid diagnostic kit for Bovine Tuberculosis, which promises quicker results in field testing scenarios for veterinary professionals.
• In October 2023, Zoetis launched an innovative TB diagnostic platform that integrates AI-driven analysis to assist veterinarians in accurately diagnosing Bovine Tuberculosis in cattle populations.

List of Leading Companies:

• IDEXX Laboratories, Inc.
• PBD Biotech Ltd
• Zoetis Services LLC
• IDvet
• Thermo Fisher Scientific Inc.
• Enfer Group
• AsureQuality Australia Pty Ltd.
• Bio-Rad Laboratories, Inc.
• Bionote USA Inc.

Report Scope: